Allen Institute

What Allen Institute does

The Allen Institute is a Seattle-based nonprofit bioscience research organization founded by Paul Allen in 2003 that operates six large-scale multidisciplinary research programs — Brain Science, Cell Science, Neural Dynamics, Immunology, Synthetic Biology (Seattle Hub), and Brain Health. Each "accelerator" combines single-cell genomics, connectomics, advanced imaging, and machine learning to map brain cells, immune cells and human cellular systems, with flagship outputs including a 1.6-petabyte mouse visual cortex reconstruction (MICrONS), a virtual mouse cortex simulation of 10 million neurons and 26 billion synapses built with Japan's Fugaku supercomputer, the Brain Knowledge Platform consolidating data from 34+ million cells across 22 species, and the iGluSnFR4 molecular glutamate indicator. The defining operational principle is a mandatory open-science mandate: every dataset, tool and model is published freely for noncommercial research through portals such as brain-map.org, allencell.org, allenimmunology.org, brain-bican.org, and microns-explorer.org, with structured APIs and the Code Ocean computational platform (v4.0, processing ~1.75M CPU hours and 150+ TB of reproducible output per month for ~250 researchers). The Institute earns no commercial revenue from its primary outputs; instead it is funded by philanthropy (notably Paul Allen's Fund for Science and Technology, the Bezos family), NIH/BRAIN Initiative federal grants, and technology partnerships with AWS, Google, NVIDIA, OpenAI and Anthropic. In June 2026 it launched the $400 million, 14-year Brain Health Accelerator — its first explicit therapeutic mandate, aimed at gene therapies for Alzheimer's, Parkinson's, Huntington's, ALS and Lewy body dementia with a stated goal of a clinical trial within five years — joining Biohub's $500 million Virtual Biology Initiative the same year. The AAV Viral Tools Collection, available for purchase, represents the institute's first move toward a hybrid open-plus-commercial tool model for gene-therapy developers.

Name

Allen Institute

Legal name

Allen Institute

Website

https://alleninstitute.org

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

251–500 employees

Short description

The Allen Institute is a Seattle-based nonprofit bioscience research organization founded in 2003 that runs six large-scale open-science "accelerators" (brain, cell, neural dynamics, immunology, synthetic biology, brain health) combining genomics, connectomics, AI and supercomputing, publishing all data and tools freely to the global research community and now expanding into gene-therapy development.

Ownership category

akta.pro rank

Product category

Bioscience Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Voluntary Health Organizations (813212)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO)

akta.pro secondary industries

Neurology/CNS Gene Therapies (HLAAACAH), AI/ML-Enabled Biologic Discovery Platforms (computational design, in silico screening) (HLAAAIAE), Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)

Keywords

• Neuroscience research
• Brain cell mapping
• Connectomics datasets
• Open science bioscience
• Immunology reference data

Headquarters

HQ city

Seattle

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Philanthropic Funding: Primary funding from private philanthropists including the Bezos family ($100 million for Brain Health Accelerator) and Paul Allen's Fund for Science and Technology ($200 million for Brain Health Accelerator). Founded by Paul Allen in 2003.
2. Federal Research Grants: Significant funding from NIH and other federal agencies for specific research initiatives including BRAIN Initiative projects and BICAN.
3. Open Science Data Sharing: As a nonprofit bioscience research organization, the Institute provides all data, tools, and models as free open resources to accelerate global scientific discovery. No commercial revenue is generated from data sharing.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

The Allen Institute is a nonprofit bioscience research organization that conducts large-scale, team-based research initiatives across brain science, cell science, neural dynamics, immunology, synthetic biology, and brain health. It produces open datasets, tools, models, and reagents (including adeno-associated viral vectors), and shares all outputs freely with the global scientific community through dedicated web portals such as brain-map.org, allencell.org, and allenimmunology.org. Its newest offering, the Brain Health Accelerator launched in June 2026 with $400M in funding, is the Institute's first explicit effort to translate foundational research into gene therapies for Alzheimer's, Parkinson's, ALS, Huntington's, and Lewy body dementia.

Product overview

The Allen Institute is a nonprofit bioscience research organization founded by Paul Allen in 2003, operating through six interconnected research accelerators: Brain Science, Cell Science, Neural Dynamics, Immunology, Synthetic Biology (Seattle Hub), and Brain Health. The Brain Science accelerator maps brain cells, circuits, and connectivity through initiatives like the Brain Knowledge Platform (developed with AWS and Google), Brain Map portal, and MICrONS Explorer. Cell Science work centers on the Allen Cell Explorer. Immunology research is accessible through the Allen Immunology Explorer. The Brain Health Accelerator (launched June 2026 with $400M funding) represents the institute's first explicit focus on treating disease through gene therapy development. All research outputs are released as open resources including datasets, analysis tools, protocols, and code, accessible through dedicated portals like allencell.org, allenimmunology.org, allenneuraldynamics.org, brain-map.org, brain-bican.org, and microns-explorer.org. The Ivy Glioblastoma Atlas provides specialized cancer research data with a public API for data access.

Differentiator

Problem solved

Functional benefit

Brands

• Ivy Glioblastoma Atlas Project: A foundational resource for exploring the anatomic and genetic basis of glioblastoma at the cellular and molecular levels, developed in partnership with the Ben and Catherine Ivy Foundation.

Products and services

• Brain Science Accelerator Large-scale research program mapping every cell, connection, and circuit in the brain through initiatives such as the Brain Knowledge Platform, Brain Map, MICrONS Explorer, and Brain-BICAN, with outputs openly shared with the global scientific community.
• Cell Science Accelerator Research program decoding how cells become tissues and translating that knowledge into open research tools and models released through the Allen Cell Explorer.
• Neural Dynamics Accelerator Research program revealing how neural activity transforms into real-world behavior, with data and tools shared via the Allen Neural Dynamics portal.
• Immunology Accelerator Research program building the deepest open reference for the healthy human immune system, with tools and data released through the Allen Immunology Explorer.
• Synthetic Biology (Seattle Hub) Research program engineering cells to record their own histories, transforming how disease progression is understood over time.
• Brain Health Accelerator Disease-translation research program developing gene therapies for neurodegenerative conditions including Alzheimer's, Parkinson's, Huntington's, ALS, and Lewy body dementia, with the explicit goal of reaching clinical trial within five years.
• Brain Knowledge Platform AI-powered neuroscience research platform built with AWS and Google that unifies and standardizes brain cell data from over 34 million cells across 22 species, enabling pattern recognition and cross-dataset comparison to accelerate brain disease research.
• Allen Cell Explorer Open data portal providing free access to cell imaging data, predictive models, and analysis tools for cell biology researchers worldwide.
• Brain Map Open-access portal providing brain atlas data including cell types, connectivity, and gene expression across multiple species for neuroscience researchers.
• MICrONS Explorer Interactive exploration tool for the MICrONS Project's 3D reconstruction of mouse visual cortex, providing access to a 1.6 petabyte dataset of over 200,000 cells and 523 million synapses.
• Brain-BICAN Open data portal for the BRAIN Initiative Cell Atlas Network, providing developing-brain cell atlas data across mice, nonhuman primates, and humans.
• Allen Immunology Explorer Open reference resource providing data and analysis tools for research on the healthy human immune system.
• Allen Neural Dynamics Open resource providing neural dynamics research data and tools to the scientific community.
• Ivy Glioblastoma Atlas Project Foundational open resource for exploring the anatomic and genetic basis of glioblastoma at cellular and molecular levels, including ISH image and RNA-Seq data with a public data API.
• AAV Viral Tools Collection Collection of adeno-associated viruses (AAVs) engineered to target specific cell types in the brain and spinal cord, sold for use in understanding neural cell function and developing gene therapies.

Quantifiable outcome

• First detailed virtual mouse cortex simulation with 10 million neurons and 26 billion synapses
• +3 more outcomes

Named customers1 record

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

Yes

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature12 records

Partnerships

22 partnerships are on record, tiered core, major and minor.

• Amazon Web ServicescoreTechnology or Integration · 2 June 2026Cloud computing infrastructure partner for Brain Health Accelerator and Brain Knowledge Platform, providing computational resources for large-scale data analysis and AI model training.
• EverythingALSmajorStrategic or Co-development Partner · 2 June 2026Partner in Brain Health Accelerator focused on ALS research, contributing to the goal of reaching clinical trial within five years.
• Biohub (Virtual Biology Initiative)coreStrategic or Co-development Partner · 29 April 2026$500 million five-year initiative to create data foundation for AI models of the human cell, with Allen Institute as a key participating institution alongside Arc Institute, Broad Institute, Human Cell Atlas, Human Protein Atlas, and Wellcome Sanger Institute.
• NVIDIAcoreTechnology or Integration · 29 April 2026Key technology partner providing accelerated computing infrastructure for Virtual Biology Initiative to process massive datasets for AI model training.
• Arc InstitutemajorStrategic or Co-development Partner · 29 April 2026Research partner in Virtual Biology Initiative focused on building massive biological datasets and AI models.
• Broad InstitutemajorStrategic or Co-development Partner · 29 April 2026Research partner in Virtual Biology Initiative contributing to global data generation efforts.
• Wellcome Sanger InstitutemajorStrategic or Co-development Partner · 29 April 2026International research partner in Virtual Biology Initiative for human cell mapping and AI model development.
• Human Cell AtlasmajorStrategic or Co-development Partner · 29 April 2026Partner organization contributing to global cell mapping efforts within Virtual Biology Initiative.
• Human Protein AtlasmajorStrategic or Co-development Partner · 29 April 2026Partner organization contributing protein mapping data to Virtual Biology Initiative.
• 50×50: Science Across AmericaminorGTM or Marketing Partner · 22 April 2026Media initiative pairing YouTube creators with scientists across all 50 US states, with Allen Institute as a founding partner to promote science education and visibility.
• OpenAImajorTechnology or Integration · 16 April 2026Early access partner for GPT-Rosalind, OpenAI's first domain-specific AI model for life sciences research, applying the model to scientific workflows for evidence synthesis, hypothesis generation, and experimental planning.
• AmgenmajorStrategic or Co-development Partner · 16 April 2026Pharmaceutical partner for GPT-Rosalind AI model testing and application in drug discovery workflows.
• ModernamajorStrategic or Co-development Partner · 16 April 2026Biotechnology partner applying GPT-Rosalind AI model to mRNA and drug discovery research workflows.
• Thermo Fisher ScientificmajorStrategic or Co-development Partner · 16 April 2026Life sciences tools company partnering to apply AI models in research workflows and experimental planning.
• Japan RIKEN Center for Computational SciencemajorStrategic or Co-development Partner · 16 April 2026Collaborative partner on Fugaku supercomputer mouse cortex simulation project, combining datasets with Japan's computational power.
• Code OceanmajorTechnology or Integration · 2 March 2026AWS-based computational research platform adopted by Allen Institute, enabling reproducible research with secure access to agentic AI within AWS environments.
• AWS (Amazon Web Services)coreTechnology or Integration · 2 March 2026Cloud infrastructure provider for Code Ocean platform and Brain Health Accelerator, enabling processing of 1.75 million CPU hours and 150+ TB monthly.
• AnthropicmajorTechnology or Integration · 4 February 2026Collaboration to integrate AI into biological research workflows, focusing on scientific data analysis, hypothesis generation, and experimental interpretation.
• HHMI (Howard Hughes Medical Institute)majorStrategic or Co-development Partner · 4 February 2026Partnership on life sciences AI integration and collaborative research, including Janelia Research Campus collaboration on iGluSnFR4 glutamate indicator technology.
• University of Electro-Communications (Japan)majorStrategic or Co-development Partner · 17 November 2025Academic partner on virtual brain simulation using Fugaku supercomputer, providing datasets and research expertise.
• GooglecoreTechnology or Integration · 13 November 2025Contributing to the Brain Knowledge Platform, an AI-based neuroscience research tool that unifies diverse brain data from multiple sources using Google's infrastructure and AI capabilities.
• Swedish Neuroscience InstitutemajorStrategic or Co-development Partner · 1 January 2004Clinical partner in Ivy Glioblastoma Atlas Project, providing research expertise and patient samples for brain tumor mapping.

Scale indicators10 records

Recent moves7 records

Expansion highlights7 records

Direct peers

• Broad Institute: The Broad Institute is a leading genomics and biomedical research organization and a co-participant in Biohub's Virtual Biology Initiative alongside Allen Institute. Both operate elite nonprofit research programs spanning genomics, cell biology, and disease, and compete for similar federal funding and scientific talent pools.
• Chan Zuckerberg Biohub: CZ Biohub launched the $500M Virtual Biology Initiative in which Allen Institute is a key participating institution. Biohub operates an open science research model similar to Allen's, focused on AI-driven biological research, making it a direct peer and partner in the shared goal of building foundational AI models of human biology.
• Salk Institute for Biological Studies: The Salk Institute is a prestigious nonprofit biological research organization focused on molecular biology, neuroscience, and genetics. Both Allen Institute and Salk operate large-scale interdisciplinary research programs, compete for NIH funding and scientific talent, and emphasize open publication of research findings.
• Wellcome Sanger Institute: Wellcome Sanger Institute is one of the world's leading genomic research centers and a co-participant in Biohub's Virtual Biology Initiative alongside Allen Institute. Both organizations generate large-scale biological reference datasets shared openly with the global research community, and Sanger's cell atlas work directly complements Allen's cell science accelerator.
• Cold Spring Harbor Laboratory: Cold Spring Harbor Laboratory is a private nonprofit research and education institution focused on cancer, neuroscience, and quantitative biology. Both organizations operate as elite nonprofit research institutes with similar funding models (federal grants plus philanthropy), compete for similar talent, and contribute open research resources to the global scientific community.
• Whitehead Institute: Whitehead Institute is a leading nonprofit biomedical research organization affiliated with MIT. Both operate as elite private research institutes focused on fundamental biological discovery, share open science principles, and compete for federal research funding and principal investigator talent in genomics and cell biology.
• Arc Institute: Arc Institute is a nonprofit research organization focused on the intersection of AI and biology, founded in 2021. It is a direct peer to Allen Institute, co-participating in the Virtual Biology Initiative, and represents an emerging competitor in the AI-driven bioscience research space with significant venture backing.

Broad incumbents

• Howard Hughes Medical Institute (HHMI): HHMI is the largest private biomedical research organization in the US and a direct peer to the Allen Institute. Both operate as nonprofit research organizations funding long-term basic science with substantial endowments. HHMI's Janelia Research Campus is an explicit Allen partner (iGluSnFR4 development) and operates a comparable model of large-scale interdisciplinary neuroscience research.
• Chan Zuckerberg Initiative (CZI): CZI is a major philanthropic biomedical research funder and the parent organization of Chan Zuckerberg Biohub. CZI's Science program funds large-scale biomedical research and infrastructure (including the Human Cell Atlas), placing it in direct competition with Allen Institute for philanthropic capital and research influence in open bioscience.

Regional players

• European Molecular Biology Laboratory (EMBL): EMBL is Europe's flagship life sciences research organization, operating across multiple countries with research programs in structural biology, genomics, and bioinformatics. EMBL's European Bioinformatics Institute (EBI) is a direct peer to Allen's open data platforms, and both compete in setting global standards for open biological data.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/allen-institute
• Xx.com/AllenInstitute
• Facebookfacebook.com/AllenInstitute

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Allen Institute